RNAi-mediated barrier modulation: synergies of the brain and eye.

Finnian Hanrahan,P. Humphries,M. Campbell
DOI: https://doi.org/10.4155/TDE.10.49
2010-10-13
Therapeutic Delivery
Abstract:Efficient drug delivery to the brain or the eye remains a key challenge for future therapies directed against neurodegenerative disorders. Indeed it has been estimated that up to 98% of clinically relevant drugs will not diffuse across the endothelial cells associated with the delicate microvasculature of the brain and inner retina. Using RNAi-based methods for suppression of claudin-5, a molecular constituent of the tight junctions associated with both the blood-brain and inner blood-retina barriers, it has been shown that these barriers can be rendered transiently and size-selectively permeable to molecules up to approximately I kDa. This review will discuss the principles upon which this technology is based and the potential therapeutic applications with regard to neurodegenerative disorders as well as common retinopathies.
What problem does this paper attempt to address?